Rituximab in Membranous Nephropathy

Philipp Gauckler*, Jae Il Shin, Federico Alberici, RITERM study group, Vincent Audard, Annette Bruchfeld, Martin Busch, Chee Kay Cheung, Matija Crnogorac, Elisa Delbarba, Kathrin Eller, Stanislas Faguer, Kresimir Galesic, Siân Griffin, Martijn W.F. van den Hoogen, Zdenka Hrušková, Anushya Jeyabalan, Alexandre Karras, Catherine King, Harbir Singh KohliGert Mayer, Rutger Maas, Masahiro Muto, Sergey Moiseev, Balazs Odler, Ruth J. Pepper, Luis F. Quintana, Jai Radhakrishnan, Raja Ramachandran, Alan D. Salama, Ulf Schönermarck, Mårten Segelmark, Lee Smith, Vladimír Tesař, Jack Wetzels, Lisa Willcocks, Martin Windpessl, Ladan Zand, Reza Zonozi, Andreas Kronbichler

*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

13 Citations (Scopus)
14 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Rituximab in Membranous Nephropathy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science